H. D. Rosas
A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease
Candidate glutamatergic and dopaminergic pathway gene variants do not influence Huntington's disease motor onset
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion
Common SNP-based haplotype analysis of the 4p16.3 Huntington disease gene region
American Journal of Human Genetics.
Population stratification may bias analysis of PGC-1alpha as a modifier of age at Huntington disease motor onset
TAA repeat variation in the GRIK2 gene does not influence age at onset in Huntington's disease
Biochemical and Biophysical Research Communications.
Map of science